Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:AQS NYSE:EVG CVE:LBL NYSE:NU CVE:SUGR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAQSAequus PharmaceuticalsC$0.01-37.5%C$0.01C$0.01▼C$0.04C$663K-0.02162,442 shs100,000 shsEVGEaton Vance Short Duration Diversified Income Fund$11.20-0.1%$10.90$10.25▼$11.45N/AN/A42,391 shs27,712 shsLBLLattice BiologicsC$0.04C$0.04C$0.03▼C$0.13C$5.13MN/A468,022 shs114,000 shsNUNU$12.84-1.5%$12.66$9.01▼$16.15$62.79B1.0748.43 million shs63.89 million shsSUGRSugarBud Craft GrowersC$13.00C$12.58C$7.30▼C$13.50C$88.66MN/A637 shs500 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAQSAequus Pharmaceuticals0.00%0.00%0.00%0.00%-85.71%EVGEaton Vance Short Duration Diversified Income Fund-0.58%+0.85%+3.50%+6.31%+2.84%LBLLattice Biologics0.00%0.00%0.00%0.00%0.00%NUNU-4.29%-4.05%+8.94%+23.72%-1.25%SUGRSugarBud Craft Growers+1.96%-2.99%+1.96%+13.54%+57.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAQSAequus PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/AN/AN/AN/AN/AN/ALBLLattice BiologicsN/AN/AN/AN/AN/AN/AN/AN/ANUNU3.2192 of 5 stars2.34.00.00.01.51.73.1SUGRSugarBud Craft GrowersN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAQSAequus Pharmaceuticals 0.00N/AN/AN/AEVGEaton Vance Short Duration Diversified Income Fund 0.00N/AN/AN/ALBLLattice Biologics 0.00N/AN/AN/ANUNU 2.50Moderate Buy$15.5020.72% UpsideSUGRSugarBud Craft Growers 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NU, AQS, SUGR, LBL, and EVG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025NUNUJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$14.50 ➝ $16.006/13/2025NUNUMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight5/14/2025NUNUSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetPositive ➝ Positive$14.00 ➝ $15.004/25/2025NUNUBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$15.00 ➝ $16.00(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAQSAequus PharmaceuticalsC$1.17M0.57C$0.00 per share5.00C($0.04) per share-0.13EVGEaton Vance Short Duration Diversified Income Fund$13.65MN/AN/AN/AN/AN/ALBLLattice BiologicsC$1.56M3.29N/AN/AC$0.00 per share40.00NUNU$11.52B5.37$0.45 per share28.77$1.59 per share8.08SUGRSugarBud Craft GrowersC$575.64M0.15C$0.12 per share110.00C$23.88 per share0.54Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAQSAequus Pharmaceuticals-C$2.86M-C$0.01N/A∞N/AN/A-1,569.60%-178.79%N/AEVGEaton Vance Short Duration Diversified Income FundN/AN/A0.00∞N/AN/AN/AN/AN/ALBLLattice BiologicsN/A-C$0.01N/A∞N/AN/AN/AN/AN/ANUNU$1.97B$0.4329.8615.110.7817.88%30.77%4.80%8/14/2025 (Estimated)SUGRSugarBud Craft GrowersC$12.12MC$0.8315.66∞N/A2.11%10.07%5.13%N/ALatest NU, AQS, SUGR, LBL, and EVG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025NUNU$0.12$0.11-$0.01$0.11$3.09 billion$3.25 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAQSAequus PharmaceuticalsN/AN/AN/AN/AN/AEVGEaton Vance Short Duration Diversified Income Fund$0.998.84%N/AN/AN/ALBLLattice BiologicsN/AN/AN/AN/AN/ANUNUN/AN/AN/AN/AN/ASUGRSugarBud Craft GrowersC$0.100.77%N/A12.05%N/ALatest NU, AQS, SUGR, LBL, and EVG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/2/2025EVGEaton Vance Short Duration Diversified Income Fund--$0.07438.2%7/15/20257/15/20257/31/20256/3/2025EVGEaton Vance Short Duration Diversified Income Fundmonthly$0.07378.5%6/16/20256/16/20256/30/20255/2/2025EVGEaton Vance Short Duration Diversified Income Fundmonthly$0.07318.4%5/15/20255/15/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAQSAequus Pharmaceuticals138.880.070.46EVGEaton Vance Short Duration Diversified Income FundN/AN/AN/ALBLLattice BiologicsN/A0.020.02NUNU0.200.540.54SUGRSugarBud Craft Growers157.271.480.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAQSAequus PharmaceuticalsN/AEVGEaton Vance Short Duration Diversified Income FundN/ALBLLattice BiologicsN/ANUNU84.02%SUGRSugarBud Craft GrowersN/AInsider OwnershipCompanyInsider OwnershipAQSAequus Pharmaceuticals14.68%EVGEaton Vance Short Duration Diversified Income FundN/ALBLLattice BiologicsN/ANUNU1.20%SUGRSugarBud Craft Growers30.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAQSAequus Pharmaceuticals12132.63 millionN/ANot OptionableEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/ANot OptionableLBLLattice BiologicsN/A128.22 millionN/ANot OptionableNUNU8,7164.82 billion4.76 billionNot OptionableSUGRSugarBud Craft Growers446.82 millionN/ANot OptionableNU, AQS, SUGR, LBL, and EVG HeadlinesRecent News About These CompaniesSugarBud Craft Growers (CVE:SUGR) Shares Down 3% - Should You Sell?July 8 at 2:41 AM | marketbeat.comSugarBud Craft Growers (CVE:SUGR) Shares Up 0.4% - Still a Buy?June 14, 2025 | marketbeat.comThe Best Kids Craft Subscription BoxesOctober 3, 2024 | nytimes.comBlood Sugar & A1COctober 2, 2024 | healthline.comHAura Craft recipesSeptember 3, 2024 | pcgamesn.comPArts and CraftsAugust 29, 2024 | architecture.comAWhat Are 30-Day No Sugar Challenges? All You Need To KnowAugust 8, 2024 | healthline.comHInfinite Craft GuideAugust 3, 2024 | ign.comIDelta Sugar Co.May 23, 2024 | wsj.comHow to make YouTube in Infinite CraftApril 18, 2024 | videogamer.comVSugar NewsMarch 10, 2024 | tvfanatic.comTCane growers protest to make Dhuri sugar mill start operationsDecember 30, 2023 | timesofindia.indiatimes.comErythritol is a sugar substitute that doesn't affect blood sugar. What to know.September 20, 2023 | usatoday.comFlorida Sugar Grower’s Digital Plans CrystallizeApril 6, 2023 | wsj.comMedical marijuana users in Mississippi: Craft your experience with variety of growersFebruary 25, 2023 | clarionledger.comC6 000 jobs at risk, cane growers complain to MPs about sugar taxFebruary 23, 2023 | iol.co.zaIDeadline is today to register for American Sugarbeet Growers Association annual meetingFebruary 22, 2023 | agweek.comASugar beet growers brace for some rough yearsFebruary 5, 2023 | grandforksherald.comG10 Ways To Lower Blood Sugar, According To ExpertsJanuary 5, 2023 | forbes.comSUGARBUD ANNOUNCES CONTINUATION OF BIA PROCEEDINGS UNDER THE CCAAOctober 18, 2022 | finance.yahoo.comSUGARBUD ANNOUNCES COMMENCEMENT OF COURT-APPROVED SALE AND INVESTMENT SOLICITATION PROCESSOctober 11, 2022 | yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI SpendingWhy Quantum Computing Inc. Is the Quiet Winner in Quantum StocksBy Jeffrey Neal Johnson | June 18, 2025View Why Quantum Computing Inc. Is the Quiet Winner in Quantum StocksPalantir’s Revenue Surge to $1B: Growth vs. ValuationBy Chris Markoch | July 9, 2025View Palantir’s Revenue Surge to $1B: Growth vs. ValuationNVIDIA’s Stock Price Hits New Highs: This Is What’s NextBy Thomas Hughes | June 26, 2025View NVIDIA’s Stock Price Hits New Highs: This Is What’s Next3 Stocks Hitting All-Time Highs With More Room to RunBy Dan Schmidt | June 27, 2025View 3 Stocks Hitting All-Time Highs With More Room to RunNU, AQS, SUGR, LBL, and EVG Company DescriptionsAequus Pharmaceuticals CVE:AQSC$0.0050 0.00 (-37.50%) As of 04/25/2025Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.Eaton Vance Short Duration Diversified Income Fund NYSE:EVG$11.20 -0.02 (-0.13%) Closing price 03:58 PM EasternExtended Trading$11.21 +0.02 (+0.13%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Eaton Vance Short Duration Diversified Income Fund is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in fixed income markets of the United States. It primarily invests in senior, secured floating-rate loans, bank deposits denominated in foreign currencies, debt obligations of foreign governmental and corporate issuers, and mortgage-backed securities. The fund invests in fixed income securities operating across diversified sectors. It invests in fixed income securities with an average duration of 1.76 years and an average credit quality of least BBB. The fund benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. It was formerly known as Eaton Vance Low Duration Diversified Income Fund. Eaton Vance Short Duration Diversified Income Fund was formed on February 28, 2005 and is domiciled in the United States.Lattice Biologics CVE:LBLC$0.04 0.00 (0.00%) As of 06/3/2021Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.NU NYSE:NU$12.84 -0.19 (-1.46%) Closing price 03:59 PM EasternExtended Trading$12.84 0.00 (-0.04%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.SugarBud Craft Growers CVE:SUGRC$13.00 0.00 (0.00%) As of 10:11 AM EasternSugarBud Craft Growers Corp. engages in the development, production, distribution, and sale of cannabis products in Canada. It offers cannabis extract, edible, and topical products through distributors and retailers, as well as to registered medical patients through CannMart.com. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Chipotle: Too Spicy for Smart Money to Resist After Stock Split Plug Power’s 20% Surge Signals New Commercial Growth Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
